These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 31211681)

  • 1. Carbapenem-Resistant Pseudomonas aeruginosa at US Emerging Infections Program Sites, 2015.
    Walters MS; Grass JE; Bulens SN; Hancock EB; Phipps EC; Muleta D; Mounsey J; Kainer MA; Concannon C; Dumyati G; Bower C; Jacob J; Cassidy PM; Beldavs Z; Culbreath K; Phillips WE; Hardy DJ; Vargas RL; Oethinger M; Ansari U; Stanton R; Albrecht V; Halpin AL; Karlsson M; Rasheed JK; Kallen A
    Emerg Infect Dis; 2019 Jul; 25(7):1281-1288. PubMed ID: 31211681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carbapenem-resistant Pseudomonas aeruginosa in Taiwan: Prevalence, risk factors, and impact on outcome of infections.
    Lin KY; Lauderdale TL; Wang JT; Chang SC
    J Microbiol Immunol Infect; 2016 Feb; 49(1):52-9. PubMed ID: 24662016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for healthcare-associated infection caused by carbapenem-resistant Pseudomonas aeruginosa.
    Tsao LH; Hsin CY; Liu HY; Chuang HC; Chen LY; Lee YJ
    J Microbiol Immunol Infect; 2018 Jun; 51(3):359-366. PubMed ID: 28988663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk Factors for Carbapenem-Resistant Pseudomonas aeruginosa, Zhejiang Province, China.
    Hu YY; Cao JM; Yang Q; Chen S; Lv HY; Zhou HW; Wu Z; Zhang R
    Emerg Infect Dis; 2019 Oct; 25(10):1861-1867. PubMed ID: 31538558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Carbapenem Resistance Mechanisms and Its Association with Pseudomonas aeruginosa Infections in the Northwest of Iran.
    Akhi MT; Khalili Y; Ghotaslou R; Yousefi S; Kafil HS; Naghili B; Sheikhalizadeh V
    Microb Drug Resist; 2018 Mar; 24(2):126-135. PubMed ID: 28654368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activity of Ceftolozane-Tazobactam against Carbapenem-Resistant, Non-Carbapenemase-Producing Pseudomonas aeruginosa and Associated Resistance Mechanisms.
    Wi YM; Greenwood-Quaintance KE; Schuetz AN; Ko KS; Peck KR; Song JH; Patel R
    Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29133568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outbreak of carbapenem-resistant Pseudomonas aeruginosa infection in a surgical intensive care unit.
    Kohlenberg A; Weitzel-Kage D; van der Linden P; Sohr D; Vögeler S; Kola A; Halle E; Rüden H; Weist K
    J Hosp Infect; 2010 Apr; 74(4):350-7. PubMed ID: 20170982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for carbapenem-resistant Pseudomonas aeruginosa infection or colonization in a Chinese teaching hospital.
    Zhang D; Cui K; Wang T; Shan Y; Dong H; Feng W; Ma C; Dong Y
    J Infect Dev Ctries; 2018 Aug; 12(8):642-648. PubMed ID: 31958327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activities of carbapenem and comparator agents against contemporary US Pseudomonas aeruginosa isolates from the CAPITAL surveillance program.
    Morrow BJ; Pillar CM; Deane J; Sahm DF; Lynch AS; Flamm RK; Peterson J; Davies TA
    Diagn Microbiol Infect Dis; 2013 Apr; 75(4):412-6. PubMed ID: 23391609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. bla
    Aruhomukama D; Najjuka CF; Kajumbula H; Okee M; Mboowa G; Sserwadda I; Mayanja R; Joloba ML; Kateete DP
    BMC Infect Dis; 2019 Oct; 19(1):853. PubMed ID: 31619192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carbapenem-resistant Pseudomonas aeruginosa strains from a Spanish hospital: characterization of metallo-beta-lactamases, porin OprD and integrons.
    Rojo-Bezares B; Estepa V; Cebollada R; de Toro M; Somalo S; Seral C; Castillo FJ; Torres C; Sáenz Y
    Int J Med Microbiol; 2014 May; 304(3-4):405-14. PubMed ID: 24594145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Carbapenem resistance in Pseudomonas aeruginosa isolated from urine cultures: prevalence and risk factors].
    Álvarez-Otero J; Lamas-Ferreiro JL; González-González L; Rodríguez-Conde I; Fernández-Soneira MJ; Arca-Blanco A; Bermúdez-Sanjurjo JR; de la Fuente-Aguado J
    Rev Esp Quimioter; 2017 Jun; 30(3):183-194. PubMed ID: 28440605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of carbapenem-resistant Pseudomonas aeruginosa on clinical and economic outcomes in a Chinese tertiary care hospital: A propensity score-matched analysis.
    Chen Z; Xu Z; Wu H; Chen L; Gao S; Chen Y
    Am J Infect Control; 2019 Jun; 47(6):677-682. PubMed ID: 30554879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outbreak of carbapenem-resistant Pseudomonas aeruginosa producing SPM-1 metallo-{beta}-lactamase in a teaching hospital in southern Brazil.
    Zavascki AP; Gaspareto PB; Martins AF; Gonçalves AL; Barth AL
    J Antimicrob Chemother; 2005 Dec; 56(6):1148-51. PubMed ID: 16239284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of carbapenem-resistant Pseudomonas aeruginosa in diabetes and cancer patients.
    Varaiya A; Kulkarni M; Bhalekar P; Dogra J
    Indian J Med Microbiol; 2008; 26(3):238-40. PubMed ID: 18695321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extensively Drug-Resistant Carbapenemase-Producing Pseudomonas aeruginosa and Medical Tourism from the United States to Mexico, 2018-2019.
    Kracalik I; Ham DC; McAllister G; Smith AR; Vowles M; Kauber K; Zambrano M; Rodriguez G; Garner K; Chorbi K; Cassidy PM; McBee S; Stoney RJ; Moser K; Villarino ME; Zazueta OE; Bhatnagar A; Sula E; Stanton RA; Brown AC; Halpin AL; Epstein L; Walters MS;
    Emerg Infect Dis; 2022 Jan; 28(1):51-61. PubMed ID: 34932447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microbiological and epidemiological characterization of imipenem-resistant Pseudomonas aeruginosa strains from a Brazilian tertiary hospital: report from the SENTRY Antimicrobial Surveillance Program.
    Ribeiro J; Mendes RE; Domingos R; França E; Silbert S; Jones RN; Sader HS
    J Chemother; 2006 Oct; 18(5):461-7. PubMed ID: 17127220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immediate and later impacts of antimicrobial consumption on carbapenem-resistant Acinetobacter spp., Pseudomonas aeruginosa, and Klebsiella spp. in a teaching hospital in Brazil: a 10-year trend study.
    Federico MP; Furtado GH
    Eur J Clin Microbiol Infect Dis; 2018 Nov; 37(11):2153-2158. PubMed ID: 30112695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extensively Drug-Resistant Pseudomonas aeruginosa Outbreak Associated With Artificial Tears.
    Grossman MK; Rankin DA; Maloney M; Stanton RA; Gable P; Stevens VA; Ewing T; Saunders K; Kogut S; Nazarian E; Bhaurla S; Mephors J; Mongillo J; Stonehocker S; Prignano J; Valencia N; Charles A; McNamara K; Fritsch WA; Ruelle S; Plucinski CA; Sosa LE; Ostrowsky B; Ham DC; Walters MS;
    Clin Infect Dis; 2024 Jul; 79(1):6-14. PubMed ID: 38315890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of extended spectrum beta-lactamases, metallo-beta-lactamases and AmpC-beta-lactamases among carbapenem resistant Pseudomonas aeruginosa isolated from burn patients.
    Neyestanaki DK; Mirsalehian A; Rezagholizadeh F; Jabalameli F; Taherikalani M; Emaneini M
    Burns; 2014 Dec; 40(8):1556-61. PubMed ID: 24767143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.